A modest proposal: targeting αv integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis
Article in Expert Opinion on Investigational Drugs (February 2024)
The most recent citing publications are shown below. View all 47 publications that cite this research output on Dimensions.
Article in Expert Opinion on Investigational Drugs (February 2024)
Article in Indian Journal of Rheumatology (February 2024)
Book chapter (January 2022)